EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...

Evidence suggests a dose-response relationship between ultra-processed food consumption and...

A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...

Content from other channels on our network

Injectable tech for fresh produce could extend shelf life

Manufacturing most impacted by ransomware in Q1 2025

Balancing packaging waste and food waste through data-driven design

Call for comment on thermolysin as a processing aid

No kidding: Australia's goatmeat exports at all-time high

CeMAT 2025 incorporates processing, packaging and more

WA Government investing $500 million to unlock industrial areas

Homegrown solar pioneer first to be funded for Solar Sunshot

Researchers show robots how to identify an object's properties through handling

UAE-funded consortium to build a waste‍-‍to‍-‍energy facility in Parkes

Digital displays in health care: benefits for patients and staff

Doctors' warning — Bupa's plans risk a US-style health model

NSWNMA: Proposed workers comp changes a "cruel blow"

Nursing and Midwifery Board waives renewal late fee until 15 June

Victoria's 2025–26 State Budget claims frontline care record